Similar articles

• Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens.

  Bettuzzi S, Davalli P, Astancolle S, Carani C, Madeo B, Tampieri A, Corti A. Bettuzzi S, et al. Cancer Res. 2000 Jan 1;60(1):28-34. Cancer Res. 2000. PMID: 10646846
• Intracellular clusterin induces G2-M phase arrest and cell death in PC-3 prostate cancer cells1.

  Scaltriti M, Santamaria A, Paciucci R, Bettuzzi S. Scaltriti M, et al. Cancer Res. 2004 Sep 1;64(17):6174-82. doi: 10.1158/0008-5472.CAN-04-0920. Cancer Res. 2004. PMID: 15342402
• Enhanced expression of the secreted form of clusterin following neoadjuvant hormonal therapy as a prognostic predictor in patients undergoing radical prostatectomy for prostate cancer.

  Miyake H, Yamanaka K, Muramaki M, Kurahashi T, Gleave M, Hara I. Miyake H, et al. Oncol Rep. 2005 Nov;14(5):1371-5. Oncol Rep. 2005. PMID: 16211311
• Benign positive margins after radical prostatectomy means a poor prognosis--con.

  Rubin MA, Montie JE. Rubin MA, et al. Urology. 2005 Feb;65(2):221-3. doi: 10.1016/j.urology.2004.08.002. Urology. 2005. PMID: 15708026 Review. No abstract available.
• Antisense oligodeoxynucleotide therapy targeting clusterin gene for prostate cancer: Vancouver experience from discovery to clinic.

  Miyake H, Hara I, Gleave ME. Miyake H, et al. Int J Urol. 2005 Sep;12(9):785-94. doi: 10.1111/j.1442-2042.2005.01173.x. Int J Urol. 2005. PMID: 16201973 Review.